Metoprolol sustained-release dropping pill and preparation method thereof
A technology for sustained-release dripping pills and angina pectoris, which is applied in the direction of pharmaceutical formulas, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., and can solve the problems of allergic reactions or adverse reactions, manufacturing and medical costs of injections High, short drug action time and other problems, to achieve the effect of improving left ventricular ejection fraction and exercise tolerance, reducing the incidence rate, and reducing the number of hospitalizations
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0041] Based on the total weight of 100g, weigh the matrix PEG4000 40%, PEG6000 20%, PEG10000 10%, stearic acid 10%, glyceryl monostearate 7%, Tween-80 3%, raw material metoprolol 10% ; Place the matrix in a heating container to heat and stir to melt, add the corresponding proportion of metoprolol, stir well, then add Tween-80 and stir evenly, under the condition of heat preservation, melt the molten or mixed liquid medicine Drop into the condensate column filled with simethicone, in which the temperature when heated and melted is 70°C, the temperature of the upper part of the condensate is 20°C, and the temperature of the bottom is -4°C; take it out after forming,
[0042] The obtained product has a 2-hour cumulative release percentage of 30%-51%, a 6-hour cumulative release percentage of 52%-74%, a 10-hour cumulative release percentage of 75%-100%, and good roundness.
Embodiment 2
[0044] Based on the total weight of 100g, weigh the matrix PEG4000 20%, PEG6000 20%, PEG10000 4.5%, stearic acid 20%, glyceryl monostearate 10%, Tween-80 0.5%, raw material metoprolol 25% Place the matrix in a heating container and heat it and stir it to melt, add the corresponding proportion of metoprolol, stir well, then add Tween-80 and stir evenly, under the condition of heat preservation, put the melted or mixed medicine The liquid drops into the condensation column filled with simethicone oil, where the temperature when heated and melted is 65°C, the temperature of the upper part of the condensate is 30°C, and the temperature of the bottom is -1°C; take it out after forming,
[0045] The obtained product has a cumulative release percentage of 25%-47% in 2 hours, a cumulative release percentage of 55%-67% in 6 hours, and a cumulative release percentage of 85%-93% in 10 hours, and has good roundness.
Embodiment 3
[0047] Based on the total weight of 100g, weigh the matrix PEG4000 50%, PEG6000 10%, PEG10000 10%, stearic acid 5%, glyceryl monostearate 5%, Tween-80 2%, raw material metoprolol 18% Place the matrix in a heating container and heat it and stir it to melt, add the corresponding proportion of metoprolol, stir well, then add Tween-80 and stir evenly, under the condition of heat preservation, put the melted or mixed medicine The liquid drops into the condensation column filled with simethicone oil, where the temperature when heated and melted is 65°C, the temperature of the upper part of the condensate is 30°C, and the temperature of the bottom is 0°C; take it out after forming,
[0048] The obtained product has a 2-hour cumulative release percentage of 63%-71%, a 6-hour cumulative release percentage of 76%-87%, a 10-hour cumulative release percentage of 77%-100%, and good roundness.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com